Almost all antipsychotics result in weight gain: a meta-analysis

PloS One
M BakM Drukker


Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses generally are restricted to second generation antipsychotics (SGA) and do not stratify for duration of AP use. It is hypothesised that patients gain more weight if duration of AP use is longer. A meta-analysis was conducted of clinical trials of AP that reported weight change. Outcome measures were body weight change, change in BMI and clinically relevant weight change (7% weight gain or loss). Duration of AP-use was stratified as follows: ≤6 weeks, 6-16 weeks, 16-38 weeks and >38 weeks. Forest plots stratified by AP as well as by duration of use were generated and results were summarised in figures. 307 articles met inclusion criteria. The majority were AP switch studies. Almost all AP showed a degree of weight gain after prolonged use, except for amisulpride, aripiprazole and ziprasidone, for which prolonged exposure resulted in negligible weight change. The level of weight gain per AP varied from discrete to severe. Contrary to expectations, switch of AP did not result in weight loss for amisulpride, aripiprazole or ziprasidone. In AP-naive patients, weight gain was much more pronounced for all AP. Given prolonged exposure, virtually all AP are associ...Continue Reading


Nov 2, 2014·Journal of Chemical Information and Modeling·Yan WangDavid Chi-Cheong Wan
Dec 2, 2015·Schizophrenia Research·Stefanie Malan-MüllerSoraya Seedat
Oct 7, 2015·Clinical Pharmacology and Therapeutics·U AnyanwaguRichard Donnelly
Mar 16, 2016·Journal of Psychiatric Research·Jaya L PadmanabhanMatcheri S Keshavan
May 25, 2016·The Psychiatric Clinics of North America·Donna AmesLynn M Yudofsky
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·C U CorrellM De Hert
May 29, 2015·Acta Psychiatrica Scandinavica·P ManuC U Correll
Sep 13, 2015·Obesity Research & Clinical Practice·David ArterburnGlenn S Gerhard
May 10, 2015·British Medical Bulletin·John Lally, James H MacCabe
Jun 19, 2015·Current Diabetes Reports·Pornpoj Pramyothin, Lalita Khaodhiar
Apr 23, 2016·Journal of Mental Health·Brenda HappellRobert Stanton
Dec 3, 2014·Nature Reviews. Endocrinology·Richard I G Holt, Alex J Mitchell
Jun 10, 2016·Expert Opinion on Pharmacotherapy·Susan L McElroyPaul E Keck
Aug 19, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sarah L VollAnne S Bassett
Nov 8, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Jui-Fen ChengHan-Yi Ching
Oct 25, 2016·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Yongmin KimWon-Myong Bahk
Dec 23, 2016·Expert Review of Neurotherapeutics·Fang FangKeming Gao
Oct 30, 2016·The Journal of the American Academy of Orthopaedic Surgeons·Peter D FabricantTheodore J Ganley
Jul 19, 2017·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tamara PringsheimDavid Gardner
Apr 7, 2018·Journal of Medical Case Reports·Nobuyuki Kobayashi, Masahiro Takano
Nov 28, 2017·Drugs·James E Frampton
Oct 21, 2017·Current Obesity Reports·Phong Ching Lee, John B Dixon
Oct 13, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·M K GebremariamO A Arah


Feb 19, 1999·Journal of Epidemiology and Community Health·C Poole, K J Rothman
Apr 22, 1999·The British Journal of Psychiatry : the Journal of Mental Science·Pierre V TranCharles M Beasley
Sep 4, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D A RevickiCharles M Beasley
Dec 10, 1999·The Journal of Clinical Psychiatry·D N OsserR L Dufresne
May 16, 2000·The Journal of Clinical Psychiatry·G L Blackburn
Jun 1, 2000·The American Journal of Psychiatry·David C HendersonD C Goff
Oct 26, 2000·Clinical Therapeutics·P N TariotI W Rak
Dec 6, 2000·The Journal of Clinical Psychiatry·B J KinonV L Stauffer
Feb 7, 2001·The American Journal of Psychiatry·P D Harvey, R S Keefe
Feb 13, 2001·Biological Psychiatry·G D TollefsonLilly Resistant Schizophrenia Study Group
Mar 10, 2001·The Journal of Clinical Psychiatry·R BruggemanJ A Temlett
Apr 4, 2001·The Australian and New Zealand Journal of Psychiatry·S Arthur
Apr 26, 2001·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R S McIntyreS H Kennedy
May 31, 2001·The Journal of Clinical Psychiatry·Todd M SangerMauricio F Tohen
May 31, 2001·The Journal of Clinical Psychiatry·C L BudmanR D Bruun
Jun 20, 2001·The Journal of Clinical Psychiatry·S J KingsburyG M Simpson
Jul 4, 2001·The British Journal of Psychiatry : the Journal of Mental Science·A HerránJ L Vázquez-Barquero
Jul 19, 2001·International Clinical Psychopharmacology·M I ButterfieldJ R Davidson
Jul 31, 2001·Journal of Clinical Psychopharmacology·Jean-Pierre LindenmayerA Iskander
Sep 26, 2001·Archives of General Psychiatry·U OsbyP Sparén
Oct 30, 2001·The Journal of Clinical Psychiatry·M M SimpsonB T Walsh
Oct 30, 2001·The Journal of Clinical Psychiatry·M SajatovicC R Bingham
Nov 13, 2001·Comprehensive Psychiatry·K N ThompsonS M Harrigan
Mar 5, 2002·The Journal of Clinical Psychiatry·Yoram Barak
May 15, 2002·Journal of Clinical Psychopharmacology·Pal CzoborJeffrey Lieberman
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Margaret O SowellJamie Dananberg
Jun 29, 2002·The Journal of Clinical Psychiatry·Steven R HirschRory O'Connor
Aug 2, 2002·Clinical Neuropharmacology·Scott P BaymillerRobert W Buchanan
Sep 21, 2002·Biological Psychiatry·Alan BreierJoseph H Friedman
Nov 6, 2002·The Journal of Clinical Psychiatry·Jean-Pierre LindenmayerJoseph P McEvoy
Nov 26, 2002·The Journal of Clinical Psychiatry·Sitra Tauscher-WisniewskiRobert B Zipursky
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Víctor Rodríguez-PérezAntonio Ciudad

Related Concepts

Metabolic Process, Cellular
Antipsychotic Effect
Meta-Analysis (Publications)
Assay OF Haloperidol
Other medications

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here